Xiaoke Bizheng (Diabetic Peripheral Neuropathy)
Conditions
Interventions
Treatment Group A:Lithocarpus Litseifolius (Hance) Chun. tea substitute (consumed as herbal tea) + topical application of Lithocarpus Litseifolius (Hance) Chun. tincture
Control Group C:acupoint application therapy using Lithocarpus Litseifolius (Hance) Chun. (implying the use of patches or plasters infused with the herb applied to specific acupuncture points)
Control Group A:topical application of Lithocarpus Litseifolius (Hance) Chun. tincture
Treatment Group B:Lithocarpus Litseifolius (Hance) Chun. tea substitute (used as a herbal tea beverage) + foot soak with Lithocarpus Litseifolius (Hance) Chun. decoction pieces (or slices for decoctio
Control Group B:foot soak with Lithocarpus Litseifolius (Hance) Chun. decoction pieces (or slices for decoction)
Treatment Group C???? C:Lithocarpus Litseifolius (Hance) Chun. tea substitute (consumed as a herbal tea) + acupoint application therapy using Lithocarpus Litseifolius (Hance) Chun. (implying the use o
Placebo control group:non-intervention
Sponsors
Nanning Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) Patients who meet the diagnostic criteria for diabetic peripheral neuropathy; 2) Age > 18 years; 3) Have the ability to understand the trial process and are willing to comply with it throughout; 4) Individuals who have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Peripheral neuropathies caused by diseases other than diabetes (such as alcoholism chemotherapy genetic causes chronic inflammatory or idiopathic neuropathies urinary retention etc.); 2) Psychiatric disorders other than mild depression; 3) Severe or unstable cardiovascular liver kidney respiratory or hematological diseases; 4) Use of other traditional Chinese medicine external therapies such as acupuncture or tuina within the past 3 months; 5) Pregnant or breastfeeding women; 6) Personnel from the research institution directly involved in the study and their immediate family members; 7) Inability to provide informed consent or follow study instructions due to language barriers severe cognitive deficits or lack of time; 8) Patients currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM (Traditional Chinese Medicine) Symptom Score;Toronto Clinical Scoring System;Therapeutic Effect of TCM Syndromes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nerve Conduction Velocity;inflammatory indicators;Ankle-Brachial Index (ABI);blood lipid levels;biochemical indicators;blood glucose level;ntioxidant indicators; | — |
Countries
china
Contacts
Public ContactWang Xiaoyong
Nanning Hospital of Traditional Chinese Medicine
Outcome results
None listed